Teresa Garcia Plascencia

2 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• COLOR LBLG1 refused line

  Artificial coloring not declared

  The product appeared to contain an artificial coloring without labeling that states that fact.

• INCONSPICU1 refused line

  Required information not conspicuous

  Information required on the label appeared not to be placed prominently or conspicuously enough to be read and understood by an ordinary consumer.

• NUTRIT LBL1 refused line

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• UNSAFE COL1 refused line

  Color additive unsafe under section 721

  The product appeared to be, or to contain, a color additive that is unsafe within the meaning of section 721(a) of the FD&C Act, the section that governs which color additives may be used and how.

Questions about Teresa Garcia Plascencia

Is Teresa Garcia Plascencia on an FDA import alert?

Yes. As of October 26, 2026, Teresa Garcia Plascencia is on the red list of FDA Import Alert 45-02, “Foods with illegal or undeclared colors”, for hot sauce (chile de arbol); FDA published the listing on January 13, 2016.

Has FDA refused shipments from Teresa Garcia Plascencia?

Yes. FDA refused 1 shipment line from Teresa Garcia Plascencia on June 2, 2023. The most recent, on June 2, 2023, was pepper, hot, with sauce, charged as UNSAFE COL (color additive unsafe under section 721).

Why did FDA refuse Teresa Garcia Plascencia's shipments?

The most frequent charges are COLOR LBLG (artificial coloring not declared, 1 line) and INCONSPICU (required information not conspicuous, 1 line).

What is Teresa Garcia Plascencia's FEI number?

Teresa Garcia Plascencia's FDA Establishment Identifier (FEI) is 3011399964.

Can shipments from Teresa Garcia Plascencia still enter the U.S.?

Shipments of hot sauce (chile de arbol) from Teresa Garcia Plascencia can be detained without physical examination under Import Alert 45-02; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).